Applied Pharmaceutical Innovation
Andrew MacIsaac is the CEO at Applied Pharmaceutical Innovation (API), an industry-led not-for-profit organization that serves as a catalyst to support the development of life science products and companies. Prior to API, Andrew MacIsaac served as the Assistant Dean at the University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences, and held various roles in the Alberta School of Business and UBC Sauder School of Business. With a background in economics and public sector management, Andrew has successfully built bridges between academia, industry, philanthropy, and government to further economic growth and societal impact. Andrew has been part of and overseen projects that have led to over $700 million in economic impact. Andrew is also a recipient of the 2022 Edifier Award for his work with API. Andrew serves on the Canadian Chamber of Commerce Life Science Strategy Council; the Edmonton Chamber of Commerce Policy Committee; the Province of Alberta Research Commercialization Working Group and Edmonton Metro Region Economic Recovery Working Group; the Calgary Life Sciences Innovation Hub Steering Committee; the Edmonton Health City Steering Committee; and several other company boards and advisory groups.
© 2022 NanoCanada. All rights reserved.